Mmit International company information, Employees & Contact Information

Payer Portrait: Health Care Service Corp. AIS Health

Trump’s New Executive Order Delivers a Win for Big Pharma AIS Health

Sandoz Launches First Interchangeable Denosumab Biosimilars at Discoun AIS Health

Analysts Downgrade Oscar’s Stock Due to ACA Exchange Uncertainty AIS Health

Payer Portrait: SCAN Health Plan AIS Health

Vertical Integration Has Helped Upend Traditional PBM Model, Form ‘New Profit Drivers’ AIS Health

Payer Portrait: L.A. Care Health Plan AIS Health

Current Market Access to GLP-1s AIS Health

Payer Portrait: CareFirst BlueCross BlueShield AIS Health

MMIT Payer Portrait: Kaiser Permanente AIS Health

MMIT Payer Portrait: Blue Cross and Blue Shield of Louisiana AIS Health

MMIT Payer Portrait: Independence Health Group AIS Health

Drug Channels Predicts More Wholesaler Vertical Integration Over Next Couple of Years AIS Health

More Commercial Health Plan Enrollees Have Copay Maximizers Than Accum AIS Health

MMIT Payer Portrait: Cambia Health Solutions AIS Health

MMIT Payer Portrait: Health Care Service Corp. AIS Health

Oncologists Express Interest in New Bladder Cancer Gene Therapy Adstil AIS Health

Payer Portrait: UPMC Health Plan AIS Health

Payer Portrait: Priority Health AIS Health

Medicare-Negotiated Drugs May Not Get Favorable Coverage In Part D: Wi AIS Health

How Could MFN Pricing Impact Commercial Market? AIS Health

Study Finds IRA Negotiation Could Threaten Late-Stage Approvals AIS Health

Warranties Can Help Mitigate Risk for Payers, Manufacturers Alike AIS Health

Payer Portrait: The Lifetime Healthcare Cos. AIS Health

New Organization Will Focus on Medical Benefit Drugs AIS Health

Payers, Immunologists Expect Yimmugo to Impact Coverage, Prescribing AIS Health

With Copay Accumulators in Legal Spotlight, Fewer People Are in Plans That Feature Them AIS Health

Trump’s DOJ Takes Surprising Stance on Agent and Broker Payments in MA AIS Health

Stand-Alone PDP Market Lives to Fight Another Day, Enrollment Data Sho AIS Health

By the Numbers: National Health Insurance Market as of 3Q 2023 AIS Health

Survey Shows That Copay Accumulators And Maximizers Continue to Be Pop AIS Health

Risk Adjustment Whistleblower Ross Recalls Exclusion, Isolation, Gasli AIS Health

Buprenorphine Remains Underutilized Despite Relaxed Regulations AIS Health

MMIT Payer Portrait: Aetna AIS Health

PBM Private-Label Units Are Drawing Pharma Contracting, Scrutiny AIS Health

Payers Say They Are Planning to Add Stelara Biosimilars to Formularies AIS Health

Shields’ Purchase of Excelera Highlights Integrated Specialty Pharmacy Industry AIS Health

Lumakras/Vectibix Combo Offers New Treatment Option for CRC AIS Health

Offering Patients Financial Incentive to Switch Therapies May Become P AIS Health

Optum Subsidiary Nuvaila Will Offer Biosimilars of Stelara, Humira AIS Health

CVS Steps Into Biosimilar Space With New Subsidiary Cordavis AIS Health

When Payers Become Producers: Inside the PBM Private-Labeling Trend Drug Channels

New FDA Approvals: FDA Approves First Generic of Emflaza AIS Health

Stelara Formulations, White Bagging Bring Complexity to IRA Negotiated Drug List AIS Health

MMIT Integrates FormTrak Market Access Tool with Veeva CRM AIS Health

Quantile Health Wants to Help Self-Insured Plans Access CGTs AIS Health

Zeposia May Have Challenges Within Ulcerative Colitis Class AIS Health

AbbVie Files Lawsuit Against Alternate Funding Company Payer Matrix Alleging ‘Fraudulent and Deceptive Scheme’ AIS Health

FDA Approves Byooviz, First Biosimilar for Ocular Use AIS Health

Alleging ‘Fraudulent and Deceptive Scheme,’ AbbVie Files Lawsuit Again AIS Health

MMIT Has Agreed to Merge With Evaluate William Blair

FDA Approves First Multiple Sclerosis Biosimilar, Sandoz’s Tyruko AIS Health

Accumulators, Maximizers, Alternative Funding Models Contribute to ‘Do AIS Health

News Briefs: Point32Health CEO Resigns, Board Chair Takes Over AIS Health

Brukinsa Gains Another Approval in Non-Hodgkin Lymphoma AIS Health

Singing the Blues: Financial Losses Spur Layoffs, Buyouts at Blue Cross Blue Shield Plans AIS Health

FDA Approves Gilead’s First-in-Class HIV Drug Sunlenca AIS Health

The Big Three PBMs’ Formulary Exclusions Continue to Grow in 2023 AIS Health

MMIT Payer Portrait: UnitedHealthcare AIS Health

Radar on Medicare Advantage AIS Health

PBM Industry Could Face Major Challenges From ERISA Suits AIS Health

Horizon BCBS Launches NovaWell to ‘Reimagine’ Behavioral Health AIS Health

Before AbbVie Lawsuit, Payer Matrix’s CBO Defended Company’s Business Model AIS Health

Copay Maximizers Face Criticism as J&J Files Legal Challenge AIS Health

Health Plan Weekly AIS Health

As States Carve Out Medicaid Drug Benefits, Managed Care Orgs Push Bac AIS Health

Humana/Anthem PBM Venture Could Attract More Blues Plans AIS Health

MMIT and Evaluate Join Forces to Offer an End-to-End View of the Pharmaceutical Market Landscape GlobeNewswire

Novartis’ Pluvicto Brings New Option to mCRPC Treatment AIS Health

Daily Research News Online no. 32165 - Pharma Intelligence Firm MMIT/Evaluate Acquires Panalgo MrWeb

Padcev Approval Gives Another Option to Treat Bladder Cancer AIS Health

MMIT & The Dedham Group Unite to Smooth Access to Therapy GlobeNewswire

MMIT/Evaluate Acquire Panalgo to Bring Speed and Trust to Pharma Analytics and Decision-Making GlobeNewswire

How to Buy MangoMan Intelligent (MMIT) in St. Vincent & Grenadines with Credit Card Online Bitget

Mobius Investment Trust - Apr 2025 | Investor trustintelligence.co.uk

MangoMan Intelligent Price: MMIT Live Price Chart, Market Cap & News Today CoinGecko